• Robert Mitchell has been hired as executive VP and chief operating officer of AngioDynamics. (Queensbury, New York), a new position. Previously, Mitchell was president/CEO and director for Millimed Holdings. AngioDynamics provides medical devices for the minimally invasive diagnosis and treatment of peripheral vascular disease.

• Jeffrey Langan has been named president/CEO of Cambridge Heart (Bedford, Massachusetts). Langan succeeds David Chazanovitz, who resigned after six years as president/CEO. Langan has served as a member of the company's' board since 1999. Langan is founder and a principal of Maine Point Associates, a business consulting firm. He also served on the business advisory board of Optherio. Cambridge Heart develops products for the noninvasive diagnosis of cardiac disease.

• Steven Van Tyle has been promoted from director of international sales to vice president of global sales at HydroCision (Billerica, Massachusetts). Prior to joining HydroCision, Van Tyle served as vice president of sales for Raymedica. He also has served in senior executive sales-and-marketing positions at Cryolife, Organogenesis, the SSI division of Hillenbrand Industries, and at Ayerst Laboratories, a division of American Home Products. HydroCision develops fluidjet-based surgical tools.

• Mark Carlson, MD, has been named chief medical officer and senior VP, clinical affairs, of the cardiac rhythm management division of St. Jude Medical (St. Paul, Minnesota). And Peter Spadaro has been promoted to the newly created position of U.S. division VP for vascular sales. Carlson most recently served as professor of government relations at Case Western Reserve University. Spadaro — who has worked in the med-tech industry for almost 25 years and has been with St. Jude for nearly 20 years — will have overall U.S. sales responsibility in the areas of cardiology, cardiac surgery and surgical atrial fibrillation (AF). St. Jude has five major focus areas that include: cardiac rhythm management, AF, cardiac surgery, cardiology and neuromodulation.

No Comments